Babesiosis: Difference between revisions

	Babesiosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Babesiosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Treatment
Medical Therapy
Prevention
Case Studies
Case #1
Babesiosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Babesiosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Babesiosis
CDC on Babesiosis
Babesiosis in the news
Blogs on Babesiosis
Directions to Hospitals Treating Babesiosis
Risk calculators and risk factors for Babesiosis

Revision as of 17:04, 23 January 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Herwaldt BL, Persing DH, Précigout EA, et al. A fatal case of babesiosis in Missouri: Identification of another piroplasm that infect humans. Ann Intern Med 1996;124:643-65.
Pershing DH, Herwaldt BL, Glaser C, et al. Infection with a Babesia-like organism in northern California. N Engl J Med 1995;332:298-303.

@@ Line 40: / Line 40: @@
 ==Treatment==
 [[Babesiosis medical therapy|Medical therapy]] | [[Babesiosis surgery|Surgical options]] | [[Babesiosis primary prevention|Primary prevention]]  | [[Babesiosis secondary prevention|Secondary prevention]] | [[Babesiosis cost-effectiveness of therapy|Financial costs]] | [[Babesiosis future or investigational therapies|Future therapies]]
-==Treatment==
-Most cases of babesiosis resolve without any specific treatment.  For ill patients, treatment is usually a two-drug regimen.  The traditional regimen of [[quinine]] and [[clindamycin]] is often poorly tolerated; recent evidence suggests that a regimen of [[atovaquone]] and [[azithromycin]] can be equally effective <ref name=Krause>{{cite journal | author = Krause P, Lepore T, Sikand V, Gadbaw J, Burke G, Telford S, Brassard P, Pearl D, Azlanzadeh J, Christianson D, McGrath D, Spielman A | title = Atovaquone and azithromycin for the treatment of babesiosis | journal = N Engl J Med | volume = 343 | issue = 20 | pages = 1454-8 | year = 2000 | id = PMID 11078770}}</ref>.  In life-threatening cases, exchange transfusion is performed.  In this procedure, the infected red blood cells are removed and replaced with fresh ones.
 ==References==